KeyBanc Maintains Avid Bioservices(CDMO.US) With Buy Rating, Maintains Target Price $14
KeyBanc analyst Paul Knight maintains $Avid Bioservices(CDMO.US)$ with a buy rating, and maintains the target price at $14.According to TipRanks data, the analyst has a success rate of 42.1% and a tot
Why Avid Bioservices Stock Is Moving Higher Wednesday
Avid Bioservices, Inc. (NASDAQ:CDMO) shares are trading higher on Wednesday following the company reporting better-than-expected 2024 fiscal-year fourth quarter sales.The Details: Avid reported fourth
Avid Bioservices Shares Rise on Upbeat FY25 Outlook
By Michael Susin Avid Bioservices shares rose on Wednesday after the group said it expects revenue to sharply increase in fiscal 2025 and to generate positive cashflow and despite posting a widened f
Avid Bioservices Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/03/2024 19.4% RBC Capital $8 → $8 Reiterates Outperform → Outperform 04/30/2024 19.4% RBC Capital $7 →
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating, Announces Target Price $16
Craig-Hallum analyst Matt Hewitt maintains $Avid Bioservices(CDMO.US)$ with a buy rating, and sets the target price at $16.According to TipRanks data, the analyst has a success rate of 39.4% and a tot
RBC Capital Maintains Avid Bioservices(CDMO.US) With Buy Rating, Maintains Target Price $8
RBC Capital analyst Sean Dodge maintains $Avid Bioservices(CDMO.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 39.2% and a t
RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Avid Bioservices Reports Mixed Q4 Results; Initiates FY24 Outlook
Earnings Call Summary | Avid Bioservices(CDMO.US) Q4 2024 Earnings Conference
The following is a summary of the Avid Bioservices, Inc. (CDMO) Q4 2024 Earnings Call Transcript:Financial Performance:Avid Bioservices reported Q4 FY2024 revenue of $43 million, an 8% increase year-o
Express News | Avid Bioservices Inc Shares up 10.3% at $7.39 After the Bell Following Results, Outlook
Avid Bioservices | 10-K: Annual report
Express News | Avid Bioservices Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Sales Results
Express News | Avid Bioservices Sees FY25 Revenue $160M-$168M Vs $164M Est
Express News | Avid Bioservices Inc: FY 2025 Revenue Guidance of Between $160 Mln and $168 Mln
Express News | Avid Bioservices Outlook FY Revenue USD 160-168 Million
Express News | Avid Bioservices Q4 Orders USD 30 Million
Express News | Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
Express News | Avid Bioservices Q4 Revenue USD 43 Million Vs. IBES Estimate USD 42.1 Million
Express News | Avid Bioservices Q4 Net Income USD -123.1 Million
Avid Bioservices 4Q Rev $43M >CDMO
Avid Bioservices 4Q Rev $43M >CDMO